(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -40.59%2.13B | ---- | -32.55%3.58B | ---- | 9.89%5.3B | ---- | 11.53%4.83B | ---- | 31.63%4.33B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 28.34%-315.37M | ---- | 27.21%-440.13M | ---- | -36.97%-604.62M | ---- | -114.24%-441.43M | ---- | -12.53%-206.04M |
Attributable subsidiary (profit) loss | ---- | 169.41%69.86M | ---- | -531.00%-100.65M | ---- | 106.65%23.35M | ---- | -7.89%-351.04M | ---- | -448.45%-325.36M |
Impairment and provisions: | ---- | 111.27%4.57B | ---- | 20.47%2.16B | ---- | 62.21%1.8B | ---- | -14.43%1.11B | ---- | 226.02%1.29B |
-Impairment of property, plant and equipment (reversal) | ---- | 122.19%4.12B | ---- | 25.89%1.85B | ---- | 41.83%1.47B | ---- | -19.37%1.04B | ---- | 255.31%1.29B |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | 371.66%322.65M | ---- | 1,126.37%68.41M | ---- | -83.74%5.58M |
-Other impairments and provisions | ---- | 45.69%449.98M | ---- | --308.86M | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | -65.47%94.28M | ---- | 489.39%273.07M | ---- | 63.90%-70.13M | ---- | 56.28%-194.25M | ---- | -74.81%-444.28M |
-Fair value of investment properties (increase) | ---- | -46.84%149.77M | ---- | 2,348.28%281.75M | ---- | 54.82%-12.53M | ---- | 86.02%-27.74M | ---- | -5,902.72%-198.45M |
-Other fair value changes | ---- | -538.99%-55.49M | ---- | 84.92%-8.68M | ---- | 65.41%-57.6M | ---- | 32.27%-166.51M | ---- | 2.00%-245.83M |
Asset sale loss (gain): | ---- | 927.87%227.26M | ---- | 128.23%22.11M | ---- | -105.83%-78.33M | ---- | -1,324.75%-38.06M | ---- | 35.89%-2.67M |
-Loss (gain) from sale of subsidiary company | ---- | 241.56%163.5M | ---- | 432.75%47.87M | ---- | 121.37%8.99M | ---- | ---42.05M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | -92.12%737K | ---- | 201.81%9.35M | ---- | 494.43%3.1M | ---- | -29.12%521K | ---- | 76.68%735K |
-Loss (gain) from selling other assets | ---- | 279.54%63.03M | ---- | 61.17%-35.11M | ---- | -2,701.76%-90.41M | ---- | 202.03%3.48M | ---- | -268.22%-3.41M |
Depreciation and amortization: | ---- | -13.61%132.52M | ---- | -14.88%153.39M | ---- | -13.13%180.19M | ---- | -0.35%207.43M | ---- | 207.07%208.16M |
-Depreciation | ---- | -13.61%132.52M | ---- | -14.88%153.39M | ---- | -13.13%180.19M | ---- | -0.35%207.43M | ---- | 207.07%208.16M |
Exchange Loss (gain) | ---- | -86.54%65.14M | ---- | 515.80%483.87M | ---- | 52.73%-116.37M | ---- | -556.23%-246.17M | ---- | -57.80%53.96M |
Special items | ---- | -29.83%2.38B | ---- | -5.24%3.39B | ---- | 30.46%3.58B | ---- | -32.29%2.74B | ---- | 20.29%4.05B |
Operating profit before the change of operating capital | ---- | -1.83%9.35B | ---- | -4.88%9.53B | ---- | 31.52%10.01B | ---- | -15.01%7.61B | ---- | 29.80%8.96B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 183.71%15.39M | ---- | 79.93%-18.38M | ---- | -1,570.53%-91.61M | ---- | 86.61%-5.48M | ---- | -1,275.31%-40.94M |
Accounts receivable (increase)decrease | ---- | -1,731.00%-5.14B | ---- | -80.72%314.87M | ---- | 112.03%1.63B | ---- | -62.60%-13.58B | ---- | -219.46%-8.35B |
Accounts payable increase (decrease) | ---- | 133.61%2.54B | ---- | -101.90%-7.55B | ---- | -12,065.60%-3.74B | ---- | -100.12%-30.75M | ---- | 12.76%24.62B |
Special items for working capital changes | ---- | -79.76%1.08B | ---- | 91.31%5.32B | ---- | -69.45%2.78B | ---- | 162.35%9.1B | ---- | 51.57%-14.59B |
Cash from business operations | -135.04%-1.53B | -6.75%8.16B | 93.07%4.36B | -20.21%8.75B | 168.72%2.26B | 97.36%10.97B | -48.08%-3.29B | -33.58%5.56B | 40.74%-2.22B | 175.90%8.37B |
Other taxs | 9.37%-1.52B | 5.02%-1.9B | 37.22%-1.68B | 54.71%-2B | 2.85%-2.68B | -134.93%-4.41B | -6.37%-2.75B | 72.89%-1.88B | 8.57%-2.59B | 30.26%-6.93B |
Interest paid - operating | 35.10%-804.18M | 9.08%-2.31B | 7.03%-1.24B | 14.46%-2.54B | 9.69%-1.33B | 8.55%-2.97B | 21.81%-1.48B | -5.99%-3.25B | -11.66%-1.89B | -15.19%-3.07B |
Special items of business | ---- | 72.95%-315.23M | ---- | -211.89%-1.17B | ---- | 84.82%-373.62M | ---- | -210.57%-2.46B | ---- | -68.25%2.23B |
Net cash from operations | -367.55%-3.85B | 19.40%3.63B | 182.29%1.44B | -5.08%3.04B | 76.71%-1.75B | 257.74%3.21B | -12.25%-7.52B | -441.37%-2.03B | 19.00%-6.7B | 103.58%595.59M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -40.59%94.01M | -28.34%315.37M | -63.91%158.23M | -27.21%440.13M | 17.88%438.46M | 36.97%604.62M | 132.20%371.95M | 114.24%441.43M | 72.82%160.18M | 12.53%206.04M |
Dividend received - investment | -38.29%11.7M | -86.06%16.6M | -80.84%18.96M | -51.35%119.09M | -20.73%98.93M | -44.24%244.77M | 87.12%124.81M | --438.97M | --66.7M | ---- |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | 113.50%10.76B | 73.87%-1.6B | 45.56%5.04B | -255.64%-6.1B |
Decrease in deposits (increase) | ---- | ---- | ---- | -195.58%-50M | ---- | -41.12%52.31M | -84.20%22.31M | -96.96%88.85M | -94.83%141.16M | 199.31%2.92B |
Sale of fixed assets | 63.06%111.56M | 336.27%292.19M | 115.11%68.41M | -36.28%66.98M | -43.37%31.8M | -67.22%105.11M | 278.60%56.16M | 142.14%320.64M | -38.70%14.83M | 1,455.49%132.42M |
Purchase of fixed assets | -92.22%-66.2M | -135.89%-162.82M | -32.73%-34.44M | 37.37%-69.02M | -73.01%-25.95M | -384.78%-110.21M | 74.26%-15M | 88.69%-22.73M | 63.37%-58.26M | -41.75%-200.92M |
Purchase of intangible assets | -33.31%-39.83M | 72.95%-37.33M | 25.76%-29.88M | -182.87%-138.02M | -414.30%-40.25M | -96.26%-48.79M | -27.48%-7.83M | 72.24%-24.86M | 86.71%-6.14M | -11.90%-89.57M |
Sale of subsidiaries | ---- | -275.97%-107.87M | -143.39%-85.8M | -93.86%61.3M | -6.13%197.76M | 346.59%999.07M | 137.82%210.69M | 76.23%-405.15M | -5.69%-557.01M | -38,609.24%-1.7B |
Acquisition of subsidiaries | ---- | -124.33%-94.54M | -132.02%-156.57M | 26.74%388.54M | 1,271.99%489.01M | 15.67%306.57M | -80.93%35.64M | 174.74%265.04M | 149.92%186.87M | 44.00%-354.6M |
Recovery of cash from investments | -71.93%1.55B | -8.00%12.95B | -47.86%5.53B | -52.48%14.08B | -4.77%10.61B | 60.97%29.63B | -42.45%11.14B | -38.65%18.41B | 40.21%19.36B | 6.51%30B |
Cash on investment | 64.54%-1.62B | 7.29%-7.96B | 18.11%-4.56B | 66.18%-8.59B | 51.66%-5.56B | -0.89%-25.39B | 44.68%-11.51B | 31.29%-25.16B | -46.71%-20.8B | -23.09%-36.62B |
Other items in the investment business | ---- | 39.03%-567.03M | ---- | 68.54%-929.97M | ---- | ---2.96B | ---- | ---- | ---- | ---- |
Net cash from investment operations | -94.64%49.11M | -13.66%4.65B | -85.32%915.65M | 56.48%5.38B | -44.28%6.24B | 147.45%3.44B | 215.51%11.19B | 38.62%-7.25B | -26.58%3.55B | -827.78%-11.81B |
Net cash before financing | -261.49%-3.8B | -1.72%8.28B | -47.48%2.36B | 26.78%8.43B | 22.00%4.49B | 171.61%6.65B | 216.82%3.68B | 17.23%-9.28B | 8.35%-3.15B | 37.31%-11.21B |
Cash flow from financing activities | ||||||||||
New borrowing | 242.49%20.74B | 13.34%16.4B | -18.80%6.06B | -48.50%14.47B | -52.59%7.46B | -24.35%28.1B | -5.27%15.73B | 0.02%37.14B | -21.45%16.61B | -12.26%37.13B |
Refund | -118.54%-22.91B | 6.15%-27.67B | 34.44%-10.48B | -13.36%-29.49B | -19.14%-15.99B | 26.68%-26.01B | 7.87%-13.42B | -12.22%-35.48B | 16.69%-14.57B | 6.01%-31.61B |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -76.23%678.91M |
Issuance of bonds | 245.28%4.13B | -40.44%4.61B | -52.11%1.2B | 351.74%7.73B | 45.79%2.5B | -78.55%1.71B | -41.20%1.71B | -0.77%7.98B | -42.33%2.91B | 230.56%8.04B |
Dividends paid - financing | -13.40%-59.91M | 3.97%-577.89M | 60.02%-52.83M | 67.09%-601.78M | -4.56%-132.13M | -0.64%-1.83B | ---126.36M | -41.71%-1.82B | ---- | ---1.28B |
Absorb investment income | 74.49%12.06M | -84.09%49.61M | -97.78%6.91M | -95.90%311.92M | -83.28%311.92M | 68.74%7.6B | 268.73%1.87B | -21.43%4.5B | -84.84%505.85M | 88.60%5.73B |
Issuance expenses and redemption of securities expenses | -91.30%-4.23B | -1.77%-5.11B | -37.34%-2.21B | 25.67%-5.03B | 64.86%-1.61B | -96.51%-6.76B | -218.20%-4.58B | 1.71%-3.44B | 58.85%-1.44B | -4,933.15%-3.5B |
Other items of the financing business | 102.27%4.95M | 22.44%-269.47M | -101.66%-218.24M | 80.13%-347.43M | -18.82%-108.23M | -1,841.04%-1.75B | -18.19%-91.09M | 74.32%-90.08M | -3,630.25%-77.07M | 90.62%-350.77M |
Net cash from financing operations | 59.46%-2.32B | 2.85%-12.58B | 24.31%-5.73B | -1,321.63%-12.95B | -796.05%-7.57B | -87.96%1.06B | -72.38%1.09B | -40.69%8.8B | -45.39%3.94B | 12.39%14.84B |
Effect of rate | -478.13%-11.79M | -8.29%39.34M | -82.72%3.12M | 425.25%42.9M | 831.83%18.05M | 44.58%-13.19M | -110.33%-2.47M | -180.31%-23.8M | 418.04%23.86M | -85.41%29.63M |
Net Cash | -81.50%-6.13B | 4.95%-4.3B | -9.35%-3.38B | -158.66%-4.52B | -164.80%-3.09B | 1,711.05%7.71B | 501.67%4.77B | -113.18%-478.36M | -79.05%792.06M | 177.51%3.63B |
Begining period cash | -19.52%17.55B | -17.03%21.81B | -17.03%21.81B | 41.37%26.29B | 41.37%26.29B | -2.63%18.6B | -2.63%18.6B | 23.69%19.1B | 23.69%19.1B | -22.48%15.44B |
Cash at the end | -38.10%11.41B | -19.52%17.55B | -20.59%18.44B | -17.03%21.81B | -0.60%23.22B | 41.37%26.29B | 17.30%23.36B | -2.63%18.6B | 3.58%19.91B | 23.69%19.1B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data